METHODS: Herein, we report a case series of 7-month-, 11-month-, and 12-month-old Syrian infants that presented with diarrhea, hematochezia, and pale appearance and were finally diagnosed with infantile inflammatory bowel disease and treated.
CONCLUSIONS: Early diagnosis and ruling out infantile inflammatory bowel diseases despite its rarity are recommended. Over and above that, new drugs such as vedolizumab, golimumab, and less invasive treatment methods should also be taken into consideration for better response and adequate remission with improved quality of life.
方法:这里,我们报告了一系列7个月的病例-,11个月-,和12个月大的叙利亚婴儿出现腹泻,便血,和苍白的外观,最后被诊断为婴儿炎症性肠病和治疗。
结论:建议早期诊断和排除婴儿炎症性肠病,尽管其罕见。除此之外,新药如维多珠单抗,戈利木单抗,和侵入性较小的治疗方法也应考虑到更好的反应和足够的缓解,提高生活质量。